These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 19164452

  • 1. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events.
    de Vogel S, Weijenberg MP, Herman JG, Wouters KA, de Goeij AF, van den Brandt PA, de Bruïne AP, van Engeland M.
    Ann Oncol; 2009 Jul; 20(7):1216-22. PubMed ID: 19164452
    [Abstract] [Full Text] [Related]

  • 2. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.
    Suehiro Y, Wong CW, Chirieac LR, Kondo Y, Shen L, Webb CR, Chan YW, Chan AS, Chan TL, Wu TT, Rashid A, Hamanaka Y, Hinoda Y, Shannon RL, Wang X, Morris J, Issa JP, Yuen ST, Leung SY, Hamilton SR.
    Clin Cancer Res; 2008 May 01; 14(9):2560-9. PubMed ID: 18451217
    [Abstract] [Full Text] [Related]

  • 3. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea.
    Kim KM, Lee EJ, Ha S, Kang SY, Jang KT, Park CK, Kim JY, Kim YH, Chang DK, Odze RD.
    Am J Surg Pathol; 2011 Sep 01; 35(9):1274-86. PubMed ID: 21836485
    [Abstract] [Full Text] [Related]

  • 4. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.
    Bagci B, Sari M, Karadayi K, Turan M, Ozdemir O, Bagci G.
    Cancer Biomark; 2016 Jun 24; 17(2):133-43. PubMed ID: 27540971
    [Abstract] [Full Text] [Related]

  • 5. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D, Pongsapich W, Heinrich U, Mann S, Mann WJ, Brieger J.
    Oncol Rep; 2012 Apr 24; 27(4):1135-41. PubMed ID: 22246327
    [Abstract] [Full Text] [Related]

  • 6. [Immunophenotypes and gene mutations in colorectal precancerous lesions and adenocarcinoma].
    Huang WT, Qiu T, Ling Y, Shi SS, Guo L, Zheng B, Lü N, Ying JM.
    Zhonghua Bing Li Xue Za Zhi; 2013 Oct 24; 42(10):655-9. PubMed ID: 24433726
    [Abstract] [Full Text] [Related]

  • 7. MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.
    Shima K, Morikawa T, Baba Y, Nosho K, Suzuki M, Yamauchi M, Hayashi M, Giovannucci E, Fuchs CS, Ogino S.
    Cancer Causes Control; 2011 Feb 24; 22(2):301-9. PubMed ID: 21140203
    [Abstract] [Full Text] [Related]

  • 8. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H, Galván JA, Helbling M, Muller DE, Karamitopoulou E, Koelzer VH, Economou M, Hammer C, Lugli A, Zlobec I.
    Int J Cancer; 2014 May 15; 134(10):2342-51. PubMed ID: 24166180
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population.
    Sinha R, Hussain S, Mehrotra R, Kumar RS, Kumar K, Pande P, Doval DC, Basir SF, Bharadwaj M.
    PLoS One; 2013 May 15; 8(4):e60142. PubMed ID: 23573237
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Correlation of MLH1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinoma.
    Santos JC, Bastos AU, Cerutti JM, Ribeiro ML.
    BMC Cancer; 2013 Feb 15; 13():79. PubMed ID: 23414134
    [Abstract] [Full Text] [Related]

  • 13. RAS/RAF mutations and their associations with epigenetic alterations for distinct pathways in Vietnamese colorectal cancer.
    Ta TV, Nguyen QN, Chu HH, Truong VL, Vuong LD.
    Pathol Res Pract; 2020 Apr 15; 216(4):152898. PubMed ID: 32089414
    [Abstract] [Full Text] [Related]

  • 14. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
    Sinicrope FA, Shi Q, Smyrk TC, Thibodeau SN, Dienstmann R, Guinney J, Bot BM, Tejpar S, Delorenzi M, Goldberg RM, Mahoney M, Sargent DJ, Alberts SR.
    Gastroenterology; 2015 Jan 15; 148(1):88-99. PubMed ID: 25305506
    [Abstract] [Full Text] [Related]

  • 15. Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis.
    Nagasaka T, Goel A, Notohara K, Takahata T, Sasamoto H, Uchida T, Nishida N, Tanaka N, Boland CR, Matsubara N.
    Int J Cancer; 2008 Jun 01; 122(11):2429-36. PubMed ID: 18240147
    [Abstract] [Full Text] [Related]

  • 16. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B.
    Asaka S, Arai Y, Nishimura Y, Yamaguchi K, Ishikubo T, Yatsuoka T, Tanaka Y, Akagi K.
    Carcinogenesis; 2009 Mar 01; 30(3):494-9. PubMed ID: 19147861
    [Abstract] [Full Text] [Related]

  • 17. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S, Hazra A, Tranah GJ, Kirkner GJ, Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Meyerhardt JA, Hunter DJ, Fuchs CS.
    Carcinogenesis; 2007 Sep 01; 28(9):1985-90. PubMed ID: 17621591
    [Abstract] [Full Text] [Related]

  • 18. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
    Wani HA, Majid S, Bhat AA, Amin S, Farooq R, Bhat SA, Naikoo NA, Beigh MA, Kadla SA.
    Eur J Cancer Prev; 2019 Mar 01; 28(2):68-75. PubMed ID: 30379684
    [Abstract] [Full Text] [Related]

  • 19. MGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosa.
    Hawkins NJ, Lee JH, Wong JJ, Kwok CT, Ward RL, Hitchins MP.
    Mod Pathol; 2009 Dec 01; 22(12):1588-99. PubMed ID: 19734844
    [Abstract] [Full Text] [Related]

  • 20. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype.
    Kim KM, Lee EJ, Kim YH, Chang DK, Odze RD.
    Am J Surg Pathol; 2010 May 01; 34(5):667-75. PubMed ID: 20305537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.